What top creators are saying about Quest Diagnostics Incorporated(DGX)

A provider of clinical laboratory and diagnostic testing services.

5 AI-extracted insights from 3 sources — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 4 scored insights about Quest Diagnostics Incorporated.

Bearish
avg -0.15
0 bullish2 neutral2 bearish
Investment Summary
Updated 14 days ago
Summary of insights about Quest Diagnostics Incorporated in the last 30 days

The Take

Recent coverage of Quest Diagnostics (DGX) is mixed but limited: two of four insights raise cybersecurity and reputational concerns, while two merely mention the company as an established laboratory competitor. No source provides a direct stock call or current investment analysis.

Bear Case

  • Cybersecurity and patient-data exposure: An unauthorized party accessed a system used by some clients that may contain sensitive patient data, raising potential reputational and liability risks (per TBPN).
  • Uncertain financial impact: The investigation was ongoing, with the scope and financial consequences not yet known (per TBPN).

AI-generated summary. Not investment advice. Learn more.

Top creators covering Quest Diagnostics Incorporated (DGX)

The 3 sources with the most insights about Quest Diagnostics Incorporated on Kazuha.

Latest insights about Quest Diagnostics Incorporated (DGX)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Friday, October 23, 2026

Bearish

Unauthorized access to a system used by some clients may have exposed patient data, creating potential cybersecurity and reputational risks. The investigation was ongoing, and the financial impact was unknown.

Bearish

An unauthorized party accessed a system that may contain sensitive patient data. The scope and financial impact were still under investigation, so the discussion advised monitoring the cybersecurity and potential liability risks without making a direct stock call.

Wednesday, October 14, 2026

Neutral

Named as a major laboratory company Theranos hoped to rival; the discussion provides no investment analysis of Quest.

Neutral

Mentioned as an established laboratory competitor and benchmark for Theranos's ambitions, without analysis of its current performance or investment prospects.

Monday, January 5, 2026

Very Bullish

Expected to see increased demand for its blood testing services as the consumer trend shifts toward proactive, preventative health and routine monitoring.

Discussed alongside Quest Diagnostics Incorporated (DGX)

Other assets that creators frequently mention in the same content as Quest Diagnostics Incorporated.

Frequently asked

Are top creators bullish or bearish on Quest Diagnostics Incorporated (DGX) right now?

Mostly bearish. In the last 30 days, 0 insights were bullish, 2 bearish, and 2 neutral about Quest Diagnostics Incorporated (DGX) across 3 financial sources indexed on Kazuha.

Which podcasters and creators cover Quest Diagnostics Incorporated (DGX) the most?

The most active sources covering Quest Diagnostics Incorporated (DGX) on Kazuha are John Coogan & Jordi Hays, @allin, All-In Podcast, LLC. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Quest Diagnostics Incorporated (DGX) are on Kazuha?

Kazuha has indexed 5 AI-extracted insights about Quest Diagnostics Incorporated (DGX) from 3 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Quest Diagnostics Incorporated (DGX)?

Creators covering Quest Diagnostics Incorporated (DGX) most frequently also discuss MRK, LH, WBA, LAZR, MRNA. See the "Discussed alongside" section above for full asset pages.